Loading cancer entity…
Loading cancer entity…
Clinical trials
102 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07844460 | 3D MRE-Based Evaluation of Vestibular Schwannoma Mechanical Properties and Histological Features | enrolling by invitation | — | 30 | Shengjing HospitalOTHER | 1 | Sep 28, 2026 | clinicaltrials |
| NCT01199978 | Hearing Outcomes Using Fractionated Proton Radiation Therapy for Vestibular Schwannoma | active not recruiting | Phase 2 | 30 | Massachusetts General HospitalOTHER | 1 | Sep 11, 2026 | clinicaltrials |
| NCT07801560 | CyberKnife Radiotherapy for the Treatment of Schwannomas(Schwannomas) | completed | — | 200 | Hartmann Oncology Radiotherapy Group, FranceOTHER | 1 | Sep 9, 2026 | clinicaltrials |
| NCT05622344 | StableEyes With Active Neurofeedback(SWAN) | recruiting | N/A | 48 | Johns Hopkins UniversityOTHER | 1 | Sep 8, 2026 | clinicaltrials |
| NCT04374305 | Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)(INTUITT-NF2) | recruiting | Phase 2 | 109 | Scott R. Plotkin, MD, PhDOTHER | 1 | Sep 2, 2026 | clinicaltrials |
| NCT04859335 | Evolution of Balance and Vestibular Function in Patients Treated With Gammaknife Radiosurgery for Vestibular Schwannoma(EQUI-GAMMA) | recruiting | N/A | 50 | University Hospital, ToulouseOTHER | 1 | Aug 11, 2026 | clinicaltrials |
| NCT05684692 | Screening Trial for Pain Relief in Schwannomatosis (STARFISH) | recruiting | Phase 2 | 40 | Massachusetts General HospitalOTHER | 1 | Jul 24, 2026 | clinicaltrials |
| NCT07713745 | Platform Research for Innovative Medicines in NF2-SWN (PRIME-NF2)(PRIME-NF2) | not yet recruiting | Phase 2 | 200 | Beijing Tiantan HospitalOTHER | 1 | Jul 20, 2026 | clinicaltrials |
| NCT07503613 | Long Term Follow-up Study of AAVAnc80-antiVEGF Gene Therapy | enrolling by invitation | — | 100 | Akouos, Inc.INDUSTRY | 1 | Jul 16, 2026 | clinicaltrials |
| NCT07707947 | Selumetinib for NF2-Related Schwannomatosis(ASSIST) | not yet recruiting | Phase 2 | 20 | Beijing Tiantan HospitalOTHER | 1 | Jul 16, 2026 | clinicaltrials |
| NCT07708285 | Luvometinib in Combination With Serplulimab for NF2-Related Tumors | not yet recruiting | Phase 1 / Phase 2 | 30 | Beijing Tiantan HospitalOTHER | 1 | Jul 16, 2026 | clinicaltrials |
| NCT07267910 | Measuring Vestibular Organ Function With Weak Alternating Current Stimulation(VESTI) | enrolling by invitation | N/A | 30 | Aalto UniversityOTHER | 1 | Jul 1, 2026 | clinicaltrials |
| NCT07493447 | Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures | recruiting | Early Phase 1 | 30 | Eben RosenthalOTHER | 1 | Jun 30, 2026 | clinicaltrials |
| NCT05576103 | Longitudinal Prospective Study of Neurocognition & Neuroimaging in Primary BT Patients | recruiting | — | 300 | Jona Hattangadi-GluthOTHER | 1 | Jun 10, 2026 | clinicaltrials |
| NCT01083966 | Super-Selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Vestibular Schwannoma | suspended | Phase 1 | 30 | Northwell HealthOTHER | 1 | Jun 1, 2026 | clinicaltrials |
| NCT03795675 | CI Following VS Removal or Labyrinthectomy | active not recruiting | N/A | 15 | Ohio State UniversityOTHER | 1 | May 13, 2026 | clinicaltrials |
| NCT06517888 | Anti-VEGF Gene Therapy Trial for Vestibular Schwannoma | recruiting | Phase 1 / Phase 2 | 27 | Akouos, Inc.INDUSTRY | 1 | Apr 6, 2026 | clinicaltrials |
| NCT05702749 | Evaluating Pre-Treatment Vestibular Physical Therapy Rehab for Patients With Vestibular Schwannomas(VS PREHAB) | recruiting | N/A | 36 | Medical College of WisconsinOTHER | 1 | Mar 24, 2026 | clinicaltrials |
| NCT04283669 | Phase 2 Clinical Trial of Crizotinib for Children and Adults With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas(NF110) | completed | Phase 2 | 12 | University of Alabama at BirminghamOTHER | 1 | Mar 13, 2026 | clinicaltrials |
| NCT04278118 | Hypofractionated Proton Therapy for Benign Intracranial Brain Tumors, the HiPPI Study(HiPPI) | recruiting | N/A | 70 | Emory UniversityOTHER | 1 | Feb 17, 2026 | clinicaltrials |
| NCT05139277 | Evaluation of the CONVIVO System | recruiting | N/A | 30 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Feb 6, 2026 | clinicaltrials |
| NCT05786144 | Vestibular Schwannoma Organoids | completed | — | 100 | Maastricht Radiation OncologyOTHER | 1 | Jan 30, 2026 | clinicaltrials |
| NCT07364955 | Vestibular Rehabilitation Protocol in Unilateral Vestibular Schwannoma | recruiting | N/A | 75 | Albert Torrents TorreroOTHER | 1 | Jan 23, 2026 | clinicaltrials |
| NCT06163664 | Role of ChatGPT in Vestibular Schwannoma Management | withdrawn | N/A | 0 | University of Southern CaliforniaOTHER | 0 | Jan 13, 2026 | clinicaltrials |
| NCT06322342 | Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent | completed | Phase 2 | 18 | Reveal Pharmaceuticals Inc.INDUSTRY | 1 | Dec 26, 2025 | clinicaltrials |
| NCT07305285 | Roy Adaptation Model Improves Mood and QOL After Giant Acoustic Neuroma | completed | N/A | 160 | West China HospitalOTHER | 1 | Dec 26, 2025 | clinicaltrials |
| NCT03406208 | Resiliency Training for Adults With Neurofibromatosis Via Live Videoconferencing | completed | N/A | 228 | Massachusetts General HospitalOTHER | 1 | Dec 24, 2025 | clinicaltrials |
| NCT03261726 | Maintaining Cochlear Patency After VIIIth Nerve Surgery | withdrawn | N/A | 0 | Henry Ford Health SystemOTHER | 1 | Dec 19, 2025 | clinicaltrials |
| NCT03079999 | Study of Aspirin in Patients With Vestibular Schwannoma | active not recruiting | Phase 2 | 97 | Massachusetts Eye and Ear InfirmaryOTHER | 1 | Dec 18, 2025 | clinicaltrials |
| NCT02282917 | Exploratory Evaluation of AR-42 Histone Deacetylase Inhibitor in the Treatment of Vestibular Schwannoma and Meningioma | terminated | Early Phase 1 | 7 | Massachusetts Eye and Ear InfirmaryOTHER | 1 | Dec 5, 2025 | clinicaltrials |
| NCT04057976 | Use of DTT to Define Facial Nerve Position in Vestibular Schwannomas | completed | N/A | 38 | King's College Hospital NHS TrustOTHER | 1 | Sep 12, 2025 | clinicaltrials |
| NCT07130851 | Mapping of Vestibular Centers Activation Using fMRI in Patients With Vestibular Schwannoma | active not recruiting | N/A | 40 | Marketa BonaventurovaOTHER | 1 | Aug 19, 2025 | clinicaltrials |
| NCT07116811 | Steroids for Facial Nerve Function Protection in Post-surgical Vestibular Schwannoma Patients(SAF-NRVS) | not yet recruiting | Phase 3 | 364 | Beijing Tiantan HospitalOTHER | 1 | Aug 12, 2025 | clinicaltrials |
| NCT07078136 | Multicenter Observational Study of Multimodal AI for Upper GI Mesenchymal Tumor Diagnosis | recruiting | — | 130 | Huazhong University of Science and TechnologyOTHER | 1 | Jul 31, 2025 | clinicaltrials |
| NCT06660082 | Early Rehabilitation Using Head Impulse Test for Acute Vestibular Deficit(KINE HIT) | recruiting | N/A | 26 | Hospices Civils de LyonOTHER | 1 | May 16, 2025 | clinicaltrials |
| NCT03095248 | Trial of Selumetinib in Patients With Neurofibromatosis Type II Related Tumors(SEL-TH-1601) | terminated | Phase 2 | 10 | Children's Hospital Medical Center, CincinnatiOTHER | 1 | Apr 22, 2025 | clinicaltrials |
| NCT04196933 | Analysis of Vestibular Compensation Following Clinical Intervention for Vestibular Schwannoma | withdrawn | N/A | 0 | Massachusetts Eye and Ear InfirmaryOTHER | 1 | Apr 16, 2025 | clinicaltrials |
| NCT02249572 | Vestibular Schwannoma - Radiosurgery or Expectation: V-REX.(V-REX) | completed | N/A | 100 | Haukeland University HospitalOTHER | 1 | Apr 2, 2025 | clinicaltrials |
| NCT04594057 | Longitudinal Recovery of Laboratory, Clinical, and Community-Based Measures of Head and Trunk Control in People With Acquired Vestibulopathy | terminated | N/A | 10 | University of UtahOTHER | 1 | Mar 19, 2025 | clinicaltrials |
| NCT06844461 | Quality of Life and Decisional Regret in Patients Affected by Acoustic Neuroma(QOL-DR-NEUROMA) | recruiting | — | 40 | IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER | 1 | Feb 25, 2025 | clinicaltrials |
| NCT05641441 | Radiosurgery Induced Ototoxicity in Patients Treated for a Vestibular Schwannoma | recruiting | — | 258 | University Hospital, GenevaOTHER | 1 | Jan 13, 2025 | clinicaltrials |
| NCT05254197 | SeOuL cOhort of Brain Tumor MONitoring Study (SOLOMON)(SOLOMON) | recruiting | — | 3,000 | Seoul National University HospitalOTHER | 1 | Dec 3, 2024 | clinicaltrials |
| NCT04648462 | Proton Therapy Research Infrastructure- ProTRAIT- Neuro-oncology | recruiting | — | 1,500 | Maastricht Radiation OncologyOTHER | 1 | Nov 26, 2024 | clinicaltrials |
| NCT03745534 | Cochlear Implantation After Gamma Knife Radiosurgery with EABR and Correlation to Postoperative Hearing Results - a Pilot Study | recruiting | — | 8 | Christoph ArnoldnerOTHER | 1 | Nov 25, 2024 | clinicaltrials |
| NCT03745560 | Intraoperative EABR for Decision Making | recruiting | — | 15 | Christoph ArnoldnerOTHER | 1 | Nov 25, 2024 | clinicaltrials |
| NCT03346889 | Vestibular Outcomes in Vestibular Schwannoma(VOVS) | active not recruiting | — | 155 | Haukeland University HospitalOTHER | 1 | Oct 30, 2024 | clinicaltrials |
| NCT06112509 | Evolution of Vestibular Function After Treatment of a Vestibular Schwannoma by Gamma-knife Radio-surgery(EVERS) | recruiting | N/A | 20 | Centre Hospitalier Universitaire de BesanconOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT06572475 | USPIO Enhanced MR Imaging in CNS Tumours (UMIC)(UMIC) | recruiting | N/A | 17 | Northern Care Alliance NHS Foundation TrustOTHER | 1 | Aug 27, 2024 | clinicaltrials |
| NCT06421805 | Establishing Prospective Mediastinal Tumor Database of PUMCH(MTDPUMCH) | recruiting | — | 2,000 | Peking Union Medical College HospitalOTHER | 1 | May 20, 2024 | clinicaltrials |
| NCT04241679 | Auditory Nerve Test System During Vestibular Schwannoma Resection(ANTS) | completed | N/A | 10 | Washington University School of MedicineOTHER | 1 | Apr 25, 2024 | clinicaltrials |
Data updated yesterdaySource updated Sep 28, 2026source: clinicaltrials